Results 1 to 10 of about 44,823 (204)

Bacteriophage Therapy: Developments and Directions [PDF]

Antibiotics, 2020
In an era of proliferating multidrug resistant bacterial infections that are exhausting the capacity of existing chemical antibiotics and in which the development of new antibiotics is significantly rarer, Western medicine must seek additional therapeutic options that can be employed to treat these infections.
Mikeljon P. Nikolich, Andrey A. Filippov
openalex   +5 more sources

Bacteriophage Therapy ofSalmonella enterica:A Fresh Appraisal of Bacteriophage Therapy [PDF]

The Journal of Infectious Diseases, 2009
The most serious criticisms leveled at bacteriophage therapy are as follows: phages induce neutralizing antibodies, phages are active only when administered shortly after bacterial infection, and phage-resistant bacteria emerge rapidly in the course of therapy.Phages lytic for several Salmonella enterica serovars were isolated by means of standard ...
Rosanna Capparelli, Nunzia Nocerino, Marco Iannaccone, Danilo Ercolini, Marianna Parlato, Chiara Medaglia, Domenico Iannelli   +6 more
openalex   +5 more sources

Clinical and Translational Perspectives on Bacteriophage Therapy for Nontuberculous Mycobacterial Diseases. [PDF]

J Microbiol Biotechnol
Ash A, Moon C, Jang J.
europepmc   +3 more sources

Feasibility and Potential Clinical Ramifications of Using Bacteriophage Therapy for <i>S. aureus</i> Necrotizing Fasciitis. [PDF]

J Clin Med
Doub JB, Dunbar D, Jain S, Manchester M, Berle L, Madhiwala J, Anderson B, Malick R, Jacobs M, Urish KL.   +9 more
europepmc   +3 more sources

Bacteriophage Therapy [PDF]

Annual Review of Microbiology, 2001
▪ Abstract  In 1917, bacteriophages were recognized as epizootic infections of bacteria and were almost immediately deployed for antibacterial therapy and prophylaxis. The early trials of bacteriophage therapy for infectious diseases were confounded, however, because the biological nature of bacteriophage was poorly understood.
A, Sulakvelidze, Z, Alavidze, J G, Morris   +2 more
  +6 more sources

Bacteriophage Therapy in Companion and Farm Animals. [PDF]

Antibiotics (Basel)
Bianchessi L, De Bernardi G, Vigorelli M, Dall'Ara P, Turin L.   +4 more
europepmc   +3 more sources

Bacteriophage Therapy as an Application for Bacterial Infection in China. [PDF]

Antibiotics (Basel), 2023
Liang S, Qi Y, Yu H, Sun W, Raza SHA, Alkhorayef N, Alkhalil SS, Salama EEA, Zhang L.   +8 more
europepmc   +3 more sources

Exploration of bacteriophage therapy as a viable alternative to combat antibiotic-resistant bacterial infections: A comprehensive <i>in vitro</i> and <i>in vivo</i> evaluation. [PDF]

Bioinformation
Mehta T, Verma S, Khangura AK, Mahapatra N, Shrivastava K, Gupta S.   +5 more
europepmc   +3 more sources

Animal Models in the Evaluation of the Effectiveness of Phage Therapy for Infections Caused by Gram-Negative Bacteria from the ESKAPE Group and the Reliability of Its Use in Humans

Microorganisms, 2021
The authors emphasize how extremely important it is to highlight the role played by animal models in an attempt to determine possible phage interactions with the organism into which it was introduced as well as to determine the safety and effectiveness ...
Martyna Cieślik, Natalia Bagińska, Andrzej Górski, Ewa Jończyk-Matysiak   +3 more
doaj   +1 more source

The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy

Antibiotics, 2021
Acinetobacter baumannii are bacteria that belong to the critical priority group due to their carbapenems and third generation cephalosporins resistance, which are last-chance antibiotics.
Natalia Bagińska, Martyna Cieślik, Andrzej Górski, Ewa Jończyk-Matysiak   +3 more
doaj   +1 more source